Explore our core therapeutic agents, fine biochemical reagents, and functional excipients engineered to international regulatory compliance standards.
Strategic intelligence on chemical synthesis, regulatory shifts, and customized CDMO/OEM methodologies in fine chemical manufacturing.
The global pharmaceutical industry is undergoing a structural transition. Sourcing organizations are shifting from transactional purchasing of Active Pharmaceutical Ingredients (APIs) to comprehensive lifecycle co-development model structures. Driven by stringent regulatory controls, such as the European Medicines Agency (EMA) and US FDA GMP guidances, chemical purity profiles require unprecedented control. High-potency APIs (HPAPIs), biological raw materials, and customized chemical intermediates now represent the fastest-growing sub-sectors within functional biochemistry.
Moreover, environmental accountability is driving green chemistry paradigms. Manufacturers must optimize raw materials utilization and minimize solvent toxicity. This requires specialized capabilities in biocatalysis and flow chemistry. Aeterna Biotech leverages these parameters to deliver highly optimized synthetic routes that lower both costs and carbon footprints.
Custom synthesis (OEM/ODM) is essential for chemical entities with complex structural properties, specific polymorph requirements, or unique formulation needs. In drug discovery and large-scale commercialization, a standard catalogue product often falls short of target biological activity or stability thresholds. Custom synthesis allows pharmaceutical developers to specify critical material attributes, including particle size distributions (PSD), enantiomeric purity ratios, and moisture control profiles.
By outsourcing customized manufacturing to a verified developer, pharmaceutical and nutraceutical brands mitigate substantial R&D and capital expenses. This lets them leverage specialized chemical reactors, advanced crystallization configurations, and robust regulatory documentation systems, accelerating their time-to-market.
| Strategic Parameters | OEM (Original Equipment Manufacturing) Model | ODM (Original Design Manufacturing) Model |
|---|---|---|
| Formula Owner | Client provides exact chemical synthetic routes and specifications. | Aeterna Biotech develops, optimizes, and owns the synthetic route. |
| QA/QC Responsibility | Verification of customer specifications via client-dictated protocols. | Full validation protocol design including stability and impurity profiles. |
| Regulatory Submissions | DMF/CEP integration support based on client documentation structure. | Aeterna Biotech manages standard dossiers and regulatory clearances. |
| Best Application Scenario | Established pharmaceutical entities seeking scalable manufacturing. | Novel compounds, nutraceutical combinations, and functional cosmetics. |
A specialized biochemical developer and exporter bridging scientific innovation and large-scale industrialization.
Shanghai Aeterna Biotech Co., Ltd. is a leading, reliable, and professional manufacturer specializing in fine chemicals, plant extracts, enzyme preparations, and nutritional ingredients. Our expertise spans research, development, production, and global sales. With decades of experience, we have built a solid reputation for delivering high-quality products and innovative solutions to a wide range of industries.
Our facilities are equipped with state-of-the-art production and testing equipment, allowing us to meet the highest industry standards. Through years of serving European and American markets, our QA/QC team has gained extensive experience in impurity analysis, precise control of flavor and fragrance formulations, and rigorous quality management. Our commitment to safety and reliability ensures that every product meets the expectations of both clients and end consumers.
Upholding the principles of credibility, integrity, and long-term partnership, we are dedicated to providing top-quality products with consistent performance, competitive pricing without compromising standards, and fast, reliable delivery to ensure smooth business operations.
Leveraging automated chemical integration, advanced logistics networks, and digital quality systems to secure global delivery pipelines.
Through automated continuous-flow synthesis and raw materials integration, Aeterna Biotech maintains high yield rates. Our scale lets us navigate global price volatility, passing cost advantages down to our formulation partners.
Operating within GMP protocols, Aeterna Biotech features a dedicated Quality Assurance (QA) unit. Every raw chemical intermediate undergoes gas chromatography (GC), high-performance liquid chromatography (HPLC), and metal residue assays before processing.
Our direct proximity to key logistics hubs in Shanghai ensures rapid global distribution. Digital tracking systems provide direct transparency for ocean freight, air transport, and cold-chain shipments.
Take a look inside our testing laboratories. Our infrastructure is equipped to handle complex validation protocols, impurity analyses, and physical-chemical profiling.
From industrial veterinary production to micro-dosed cosmetic therapeutics, our APIs adapt to diverse product matrices.
Veterinary drugs, such as Oxytetracycline Hydrochloride, are manufactured to meet bio-availability thresholds in animal feed and water matrices. Ensuring chemical stability in diverse storage conditions prevents degradation, protecting downstream agricultural operations.
Ingredients like Sodium Hyaluronate require precise molecular weight distribution to optimize skin penetration and moisture retention. Aeterna Biotech offers customized molecular ranges tailored for deep hydration serums and topical emulsions.
Our probiotic strains, such as Lactobacillus Acidophilus, are optimized for shelf stability and gastric survival rates, making them suitable for health supplements and functional food applications.
Technical answers to key compliance, synthesis, and logistical inquiries for global sourcing managers.
Every product batch is shipped with a comprehensive Certificate of Analysis (COA), detailed Material Safety Data Sheets (MSDS), and gas/liquid chromatography trace outputs. For regulated markets, we provide DMF (Drug Master File) technical data sheets to support your regulatory submissions.
Our QA/QC team utilizes Waters HPLC and atomic absorption spectrophotometers to detect trace heavy metals and organic impurities. This ensures our chemical products consistently meet or exceed USP, EP, and ChP purity standards.
Lead times depend on the molecular complexity and synthesis pathway. Process optimization and lab trials typically take 4–6 weeks, followed by pilot production. We provide detailed timeline projections during our initial technical consultations.
Yes, our probiotic strains, including Lactobacillus Acidophilus, undergo a specialized stabilization process. This helps maintain high viability counts (up to 200 Billion CFU/g) under standard ambient storage conditions.
High-purity raw materials and ingredients optimized for pharmaceuticals, cosmetics, and functional nutrition.
Aeterna Biotech
